- Home
- USLM vs ZLAB Comparison
USLM vs ZLAB Comparison
Compare USLM & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | USLM | ZLAB |
|---|---|---|
| Founded | 1948 | 2013 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 2.0B |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | USLM | ZLAB |
|---|---|---|
| Price | $118.57 | $17.66 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $57.22 |
| AVG Volume (30 Days) | 76.3K | ★ 840.9K |
| Earning Date | 02-02-2026 | 11-06-2025 |
| Dividend Yield | ★ 0.19% | N/A |
| EPS Growth | ★ 32.23 | N/A |
| EPS | ★ 4.55 | N/A |
| Revenue | $364,849,000.00 | ★ $441,629,000.00 |
| Revenue This Year | $22.64 | $26.16 |
| Revenue Next Year | $8.38 | $30.62 |
| P/E Ratio | $27.06 | ★ N/A |
| Revenue Growth | 20.27 | ★ 24.14 |
| 52 Week Low | $80.47 | $16.82 |
| 52 Week High | $137.96 | $44.34 |
Technical Indicators
Market Signals| Indicator | USLM | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 38.44 | 35.50 |
| Support Level | $123.45 | $17.50 |
| Resistance Level | $128.13 | $17.97 |
| Average True Range (ATR) | 4.17 | 0.62 |
| MACD | -0.79 | 0.26 |
| Stochastic Oscillator | 0.00 | 37.90 |
Price Performance
Historical ComparisonAbout USLM United States Lime & Minerals Inc.
United States Lime & Minerals Inc is engaged in the business of manufacturing lime and limestone products including PLS, quicklime, hydrated lime and lime slurry. It supplies its products predominantly to the construction (including highway, road, and building contractors), industrial (including paper and glass manufacturers), environmental (including municipal sanitation and water treatment facilities and flue gas treatment processes), metals (including steel producers), oil and gas services, roof shingle manufacturers and agriculture (including poultry and cattle feed producers) industries. The company operates through its Lime and Limestone Operations segment.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.